Literature DB >> 15548491

Neurosyphilis in the modern era.

M Timmermans1, J Carr.   

Abstract

OBJECTIVE: To review the nature of the presentation of neurosyphilis, the value of diagnostic tests, and the classification of the disease.
METHODS: A retrospective review was carried out of the records of patients who had been identified as possible cases of neurosyphilis by a positive FTA-abs test in the CSF. The review extended over 10 years at a single hospital which served a population of mixed ancestry in a defined catchment area in the Western Cape province of South Africa. Patients were placed in predefined diagnostic categories, and clinical, radiological, and laboratory features were assessed.
RESULTS: 161 patients met diagnostic criteria for neurosyphilis: 82 presented with combinations of delirium and dementia and other neuropsychiatric conditions, and the remainder had typical presentations such as stroke (24), spinal cord disease (15), and seizures (14). The average age of presentation ranged from 35.9 to 42.6 years in the different categories of neurosyphilis. Of those followed up, 77% had residual deficits from their initial illness. Cerebrospinal fluid (CSF) VDRL was positive in 73% of cases.
CONCLUSIONS: The diagnosis of neurosyphilis can be made with reasonable certainty if there is an appropriate neuropsychiatric syndrome associated with a positive CSF VDRL. If the VDRL is negative, a positive FTA-abs in an appropriate clinical setting, associated with raised CSF cell count, protein, or IgG index, is a useful method of identifying neurosyphilis. Tabes dorsalis has become uncommon, but this is likely to be the only manifestation of neurosyphilis that has been altered during the antibiotic era.

Entities:  

Mesh:

Year:  2004        PMID: 15548491      PMCID: PMC1738873          DOI: 10.1136/jnnp.2004.031922

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  18 in total

1.  Epidemics of syphilis in the Russian Federation: trends, origins, and priorities for control.

Authors:  L Tichonova; K Borisenko; H Ward; A Meheus; A Gromyko; A Renton
Journal:  Lancet       Date:  1997-07-19       Impact factor: 79.321

2.  Study of fluorescent treponemal antibody test on cerebrospinal fluid using monospecific anti-immunoglobulin conjugates IgG, IgM, and IgA.

Authors:  G Leclerc; M Giroux; A Birry; S Kasatiya
Journal:  Br J Vener Dis       Date:  1978-10

3.  Neurosyphilis. A study of 241 patients.

Authors:  H Hooshmand; M R Escobar; S W Kopf
Journal:  JAMA       Date:  1972-02       Impact factor: 56.272

4.  Fluorescent treponemal antibody-absorption (FTA-ABS) test for syphilis.

Authors:  W E Deacon; J B Lucas; E V Price
Journal:  JAMA       Date:  1966-11-07       Impact factor: 56.272

5.  Neurosyphilis: a changing diagnostic problem?

Authors:  E C Wolters
Journal:  Eur Neurol       Date:  1987       Impact factor: 1.710

6.  Neurosyphilis in the antibiotic era.

Authors:  J M Burke; D R Schaberg
Journal:  Neurology       Date:  1985-09       Impact factor: 9.910

7.  Neurosyphilis today.

Authors:  L Luxon; A J Lees; R J Greenwood
Journal:  Lancet       Date:  1979-01       Impact factor: 79.321

8.  Modified neurosyphilis in the Cape Peninsula.

Authors:  N Joyce-Clarke; A C Molteno
Journal:  S Afr Med J       Date:  1978-01-07

9.  Neurosyphilis.

Authors:  R P Simon
Journal:  Arch Neurol       Date:  1985-06

10.  Syphilis tests in diagnostic and therapeutic decision making.

Authors:  G Hart
Journal:  Ann Intern Med       Date:  1986-03       Impact factor: 25.391

View more
  39 in total

1.  Status epilepticus secondary to luetic encephalitis: evolution of neuroimaging findings.

Authors:  Angel Sesar; Manuel Arias; Ignacio Requena; Inmaculada Pereiro
Journal:  J Neurol       Date:  2008-02-25       Impact factor: 4.849

2.  Update on neurosyphilis.

Authors:  Christina M Marra
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

3.  Comparison of the cerebrospinal fluid (CSF) toluidine red unheated serum test and the CSF rapid plasma reagin test with the CSF venereal disease research laboratory test for diagnosis of neurosyphilis among HIV-negative syphilis patients in China.

Authors:  Lin Zhu; Xin Gu; Rui-Rui Peng; Cuini Wang; Zixiao Gao; Pingyu Zhou; Ying Gao; Mei Shi; Zhifang Guan; Arlene C Seña
Journal:  J Clin Microbiol       Date:  2013-12-11       Impact factor: 5.948

4.  Acute and chronic brain infarcts on MR imaging in a 20-year-old woman with acute posterior multifocal placoid pigment epitheliopathy.

Authors:  A N Bugnone; F Hartker; M Shapiro; H S Pineless; G Velez
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

5.  Neurocognitive and psychiatric changes as the initial presentation of neurosyphilis.

Authors:  Cecilia T Costiniuk; Paul A MacPherson
Journal:  CMAJ       Date:  2013-02-25       Impact factor: 8.262

6.  Hippocampal MR spectroscopic abnormalities in a cohort of syphilitic patients with HIV and neurosyphilis infection.

Authors:  Pui-Wai Chiu; Henry Ka-Fung Mak; Yung Chan; Tao Chan; King-Man Ho
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-12-15

7.  An unusual cause for hyponatremia with seizures.

Authors:  Kushal Naha; G Vivek; Sowjanya Dasari; M Manthappa; Lorraine Dias; Raviraja Acharya
Journal:  BMJ Case Rep       Date:  2012-03-20

Review 8.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Huidy Shu; Aissa Haman; James J Sejvar; Bruce L Miller
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

9.  Differential diagnosis of white matter diseases in the tropics: An overview.

Authors:  Lekha Pandit
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

10.  Neurosyphilis in the age of AIDS: clinical and laboratory features.

Authors:  Lívia Leite Góes Gitaí; Paulo Samandar Jaláli; Osvaldo Massaiti Takayanagui
Journal:  Neurol Sci       Date:  2009-09-19       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.